Pirarubicin
![]() | |
Systematic (IUPAC) name | |
---|---|
(3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-4-O-[(2R)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranoside | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Identifiers | |
CAS Number |
72496-41-4 ![]() |
ATC code | L01DB08 (WHO) |
PubChem | CID 3033521 |
ChemSpider |
2298189 ![]() |
UNII |
D58G680W0G ![]() |
KEGG |
D01885 ![]() |
ChEMBL |
CHEMBL1398373 ![]() |
Synonyms | (9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2R)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione |
Chemical data | |
Formula | C32H37NO12 |
Molar mass | 627.63 g/mol |
| |
| |
![]() ![]() |
Pirarubicin (INN) is an anthracycline drug. An analogue of the anthracycline antineoplastic antibiotic doxorubicin. Pirarubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. This agent is less cardiotoxic than doxorubicin and exhibits activity against some doxorubicin-resistant cell lines.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.